Cognition Therapeutics, Inc. (NASDAQ:CGTX) Given Average Rating of “Buy” by Analysts
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been given a consensus recommendation of “Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy […]
Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) have been given a consensus recommendation of “Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy […]
